secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0001425450-24-000090
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q3 record revenue $54.6M (+37% YoY); raises FY guidance to $202-204M
--------------------------------------------------------------------------------

- Revenue $54.6M (+37% YoY); domestic up 45%, international up 12%.
- Net loss $7.9M ($0.34/shr) vs $4.6M ($0.20) YoY; $3.2M one-time refinancing expense.
- Adjusted EBITDA $4.0M vs $3.6M in Q3 2023; gross margin 73% vs 77%.
- Raised FY 2024 revenue guidance to $202-204M from $200-203M; reaffirmed Adj. EBITDA $8-9M.
- Helped record >33,000 children (+50% YoY); Trauma & Deformity +31%, Scoliosis +52%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545024000090/0001425450-24-000090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545024000090/kids-20241106.htm
  HTML page:      https://secwatch.observer/filing/0001425450-24-000090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer